D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.59% |
| 2 | Technology | 18.36% |
| 3 | Consumer Discretionary | 9.46% |
| 4 | Financials | 6.95% |
| 5 | Healthcare | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Nokia
NOK
$59.8B
| $6.02M | 0.01% |
1,700,000
+1,660,500
| +4,204% | +$5.91M |
|
1627
Tenet Healthcare
THC
$21.1B
| $6.01M | 0.01% |
57,214
-33,400
| -37% | -$3M |
|
1628
CALL
Teva Pharmaceutical Industries Limited
TEVA
$45.5B
| $6.01M | 0.01% |
425,700
+389,400
| +1,073% | +$4.91M |
|
1629
Turning Point Brands
TPB
$1.37B
| $6M | 0.01% |
204,747
+26,545
| +15% | +$677K |
|
1630
Toro Company
TTC
$8.85B
| $5.99M | 0.01% |
65,412
-19,063
| -23% | -$1.76M |
|
1631
CALL
Prudential Financial
PRU
$40.8B
| $5.99M | 0.01% |
51,000
-74,800
| -59% | -$8.06M |
|
1632
Orion
OEC
$324M
| $5.99M | 0.01% |
254,534
-7,824
| -3% | -$181K |
|
1633
Avnet
AVT
$7.89B
| $5.98M | 0.01% |
120,707
+70,861
| +142% | +$3.32M |
|
1634
Teekay Tankers
TNK
$3.5B
| $5.98M | 0.01% |
102,432
-129,700
| -56% | -$7.33M |
|
|
B
1635
CALL
Barrick Mining
B
$71.3B
| $5.97M | 0.01% |
+358,700
| New | +$5.61M |
|
|
VRNT
1636
DELISTED
Verint Systems
VRNT
| $5.95M | 0.01% |
179,615
-187,169
| -51% | -$5.6M |
|
|
SUPV
1637
Grupo Supervielle
SUPV
$704M
| $5.95M | 0.01% |
1,041,249
+377,718
| +57% | +$1.67M |
|
1638
PUT
HP
HPQ
$31B
| $5.94M | 0.01% |
+196,600
| New | +$5.79M |
|
1639
PUT
ResMed
RMD
$32.5B
| $5.94M | 0.01% |
30,000
| – | – |
|
1640
Matsons
MATX
$6.97B
| $5.94M | 0.01% |
52,849
-19,989
| -27% | -$2.25M |
|
1641
Ranpak Holdings
PACK
$341M
| $5.91M | 0.01% |
751,441
-8,806
| -1% | -$46.3K |
|
|
USAR
1642
USA Rare Earth Inc
USAR
$5.77B
| $5.9M | 0.01% |
563,823
+425,000
| +306% | +$4.43M |
|
1643
Fulcrum Therapeutics
FULC
$287M
| $5.9M | 0.01% |
625,176
+127,497
| +26% | +$1.14M |
|
1644
PUT
Pinterest
PINS
$10.5B
| $5.89M | 0.01% |
+170,000
| New | +$6.18M |
|
1645
Blackstone
BX
$93.8B
| $5.86M | 0.01% |
44,643
+31,483
| +239% | +$3.93M |
|
1646
Porch Group
PRCH
$1.8B
| $5.86M | 0.01% |
1,360,271
+696,809
| +105% | +$2.08M |
|
1647
Ally Financial
ALLY
$12.2B
| $5.85M | 0.01% |
144,142
+122,526
| +567% | +$4.48M |
|
1648
Dana Inc
DAN
$3.21B
| $5.84M | 0.01% |
+460,153
| New | +$5.97M |
|
|
B
1649
DELISTED
Barnes Group Inc.
B
| $5.84M | 0.01% |
157,258
-114,112
| -42% | -$3.93M |
|
1650
PUT
Match Group
MTCH
$9.92B
| $5.84M | 0.01% |
160,900
+14,800
| +10% | +$535K |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co's Q1 2024 filing shows 655 new, 1,367 increased, 1,722 reduced and 634 closed positions. Its largest new stake was Arm: 2,379,839 shares worth $297M. The largest sale was NVIDIA, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.